Comparison between Advanta Enterprises IPO and Rodec Pharma IPO.
Advanta Enterprises IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rodec Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advanta Enterprises IPO is up to ₹0.00 Cr whereas the issue size of the Rodec Pharma IPO is up to ₹0.00 Cr. The final issue price of Advanta Enterprises IPO is and of Rodec Pharma IPO is .
| Advanta Enterprises IPO | Rodec Pharma IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,61,05,578 shares | 56,50,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 3,61,05,578 shares | 56,50,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Advanta Enterprises IPO opens on , while Rodec Pharma IPO opens on . The closing date of Advanta Enterprises IPO and Rodec Pharma IPO is , and , respectively.
Advanta Enterprises IPO P/E ratio is , as compared to Rodec Pharma IPO P/E ratio of .
| Advanta Enterprises IPO | Rodec Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.21 | 92.40 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 93.86% | 36.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 52.67% | 40.94% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 38.33% | 36.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Advanta Enterprises IPO Retail Individual Investors (RII) are offered 0 shares while in Rodec Pharma IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Advanta Enterprises IPO and 0 shares in Rodec Pharma IPO.
| Advanta Enterprises IPO | Rodec Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Advanta Enterprises IPO subscribed in total, whereas Rodec Pharma IPO subscribed .
